Literature DB >> 4961566

Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins.

J A Glomset, E T Janssen, R Kennedy, J Dobbins.   

Abstract

The role of the plasma lecithin:cholesterol acyltransferase reaction in the esterification of the cholesterol of human and baboon plasma high density lipoproteins has been studied. Human plasma was incubated in vitro, and the initial rate of cholesterol esterification in lipoprotein fractions obtained by chromatography on hydroxylapatite was determined. The rate of esterification was greater in the high density lipoprotein fraction than in the low density lipoprotein fraction. High density lipoproteins from human and baboon plasma were filtered through columns of Sephadex G 200, and the relative concentrations in the effluent of key lipids involved in the acyltransferase reaction were determined. The ratio of esterified to unesterified cholesterol varied across the lipoprotein peak obtained from either type of plasma. The relative concentration of lecithin compared to sphingomyelin also varied across the peaks obtained with human high density lipoproteins. When human or baboon plasma was incubated with cholesterol-(14)C and the high density lipoproteins were filtered through Sephadex, the specific activity of the esterified cholesterol varied across the lipoprotein peak. Similar results were obtained when plasma esterified cholesterol was labeled in vivo by the injection of labeled mevalonate into baboons. The data suggest that the acyltransferase reaction is the major source of the esterified cholesterol of the high density lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4961566

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

1.  Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.

Authors:  N S Shachter; T Ebara; R Ramakrishnan; G Steiner; J L Breslow; H N Ginsberg; J D Smith
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins.

Authors:  G Utermann; H J Menzel; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1975

3.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

4.  Effect of hypercholesteremia on the activity of serum lecithin-cholesterol acyltransferase.

Authors:  I L Shapiro; J A Jastremsky; D Kritchevsky
Journal:  Lipids       Date:  1968-07       Impact factor: 1.880

Review 5.  Lymphatic transport of high-density lipoproteins and chylomicrons.

Authors:  Gwendalyn J Randolph; Norman E Miller
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

6.  Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.

Authors:  J M Hoeg; S Santamarina-Fojo; A M Bérard; J F Cornhill; E E Herderick; S H Feldman; C C Haudenschild; B L Vaisman; R F Hoyt; S J Demosky; R D Kauffman; C M Hazel; S M Marcovina; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

7.  Lipoproteins in LCAT-deficiency.

Authors:  G Utermann; W Schoenborn; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1972

8.  Net esterification in vitro of plasma cholesterol in human primary hyperlipidemia.

Authors:  Y L Marcel; H D Fabien; J Davignon
Journal:  Lipids       Date:  1971-10       Impact factor: 1.880

9.  Central role of high density lipoprotein in plasma free cholesterol metabolism.

Authors:  C C Schwartz; Z R Vlahcevic; M Berman; J G Meadows; R M Nisman; L Swell
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

10.  High density lipoprotein metabolism in man.

Authors:  C B Blum; R I Levy; S Eisenberg; M Hall; R H Goebel; M Berman
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.